Abstract:Mesoporous silica nanoparticles (MSNs) have shown incredible potential for drug delivery owing to their orderly mesoporous structure, high surface area, pore volume, and biocompatibility. pH-responsive MSN-based drug delivery systems may be used to deliver anticancer agents. This manuscript reports MSNs exclusively for pH-based drug delivery for controlled delivery applications. This study reports the development of positively charged MSNs under acidic conditions using a "modified sol–gel method." The developed MSNs were loaded with doxorubicin, a positively charged anticancer drug, lidocaine, a neutral topical anesthetic, and indomethacin, a negatively charged anti-inflammatory drug, by adsorption method. ATR-FT-IR spectra and XRD patterns of the neat MSNs and drug-loaded MSNs were obtained to study their physicochemical nature. SEM and TEM images showed the hexagonal arrangement of the neat MSNs and the changes observed after drug loading. The pH-responsive behavior of the MSNs loaded with the drugs was also characterized. From the results, we observed that the MSNs could be triggered to release the drugs by the pH of the solution and, therefore, could be a potential candidate for pH-based drug delivery systems. In vitro cytotoxicity assays were performed to study the anticancer activity of DOX-loaded MSNs. These in vitro studies were performed using three cancer cell lines, viz., MG-63 osteosarcoma cells, MCF-7 breast cancer cells, and MDA-MB-231 breast cancer cells. These assays showed effective inhibitory activity of the DOX-loaded MSNs. Furthermore, we have applied mathematical modeling to investigate the release of DOX from the pH-responsive MSNs in different pH environments. From the obtained modeling results, the sustained release of DOX from the non-functionalized MSNs fits well with the saturation kinetics model. Therefore, these positively charged MSNs synthesized by the modified sol–gel method can be potentially used for cancer therapy.

Anticancer Drug Release System Based on Hollow Silica Nanocarriers Triggered by Tumor Cellular Microenvironments

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity.

Ph-Sensitive Nano-Systems for Drug Delivery in Cancer Therapy.

Multistage Ph-Responsive Mesoporous Silica Nanohybrids with Charge Reversal and Intracellular Release for Efficient Anticancer Drug Delivery

In Situ Monitoring of Intracellular Controlled Drug Release from Mesoporous Silica Nanoparticles Coated with Ph-Responsive Charge-Reversal Polymer

Ph-Responsive Mesoporous Silica Nanoparticles Employed in Controlled Drug Delivery Systems for Cancer Treatment

Ultra-small Mesoporous Silica Nanoparticles As Efficient Carriers for Ph Responsive Releases of Anti-Cancer Drugs

pH-responsive nanoparticles for cancer drug delivery

pH sensitive mesoporous nanohybrids with charge-reversal properties for anticancer drug delivery

pH-controllable drug carrier with SERS activity for targeting cancer cells.

Cell Microenvironment Stimuli-Responsive Controlled-Release Delivery Systems Based on Mesoporous Silica Nanoparticles

pH-responsive drug release from positively charged mesoporous silica nanoparticles and their potential for anticancer drug delivery

pH-responsive mesoporous silica drug delivery system for targeted cancer chemotherapy

A pH-responsive biomimetic drug delivery nanosystem for targeted chemo-photothermal therapy of tumors

A Preloaded Amorphous Calcium Carbonate/Doxorubicin@Silica Nanoreactor for Ph‐responsive Delivery of an Anticancer Drug

Hollow Mesoporous Silica Nanoparticles Facilitated Drug Delivery Via Cascade Ph Stimuli in Tumor Microenvironment for Tumor Therapy.

pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery

Poly(2-(diethylamino)ethyl Methacrylate)-Based, Ph-Responsive, Copolymeric Mixed Micelles for Targeting Anticancer Drug Control Release

A Ph-Responsive Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Breast Cancer Therapy

Highly cell-penetrating and ultra-pH-responsive nanoplatform for controlled drug release and enhanced tumor therapy